NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

IPCA Laboratories Limited (NSE: IPCALAB)

 
IPCALAB Technical Analysis
4
As on 30th Sep 2022 IPCALAB SHARE Price closed @ 915.00 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 1217.42 & Sell for SHORT-TERM with Stoploss of 933.79 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

IPCALABSHARE Price

Open 905.35 Change Price %
High 917.45 1 Day 5.60 0.62
Low 896.00 1 Week 41.05 4.70
Close 915.00 1 Month 9.80 1.08
Volume 193371 1 Year -1496.35 -62.05
52 Week High 2637.50 | 52 Week Low 964.55
 
IPCALAB CURRENT MONTH FUTURE
Close 916.40
Contracts Traded 425100
Open Intrest 1147250
Change In O.I 2.20 %
Lot Size 650
IPCALAB CURRENT MONTH OPTION
Most Active Call 1000.00
Most Active put 800.00
Highest O.I Buildup Call 1000.00
Highest O.I Buildup Put 800.00
Expiry Date 2022-10-27
IPCALAB ALL MONTHS OPTIONS
For All IPCALAB Options Click Here
 
NSE INDIA Most Active Stocks
IDEA 8.80 3.53%
SUZLON 8.70 2.96%
PNB 36.55 4.73%
YESBANK 15.65 0.97%
ZOMATO 62.35 1.88%
TATASTEEL 99.30 2.53%
JPPOWER 7.35 3.52%
POWERGRID 212.20 2.02%
RENUKA 59.30 1.37%
IDFCFIRSTB 49.85 4.40%
 
NSE INDIA Top Gainers Stocks
CMICABLES 21.70 19.89%
GPTINFRA 139.75 19.04%
ANANTRAJ 97.05 16.86%
IRISDOREME 248.95 15.47%
ADANIGREEN 2260.80 12.81%
TIL 120.20 12.76%
TIL 120.20 12.76%
TIL 120.20 12.76%
TRIL 59.65 12.65%
TRIL 59.65 12.65%
 
NSE INDIA Top Losers Stocks
INSECTICID 718.40 -25.65%
GAYAHWS 0.70 -6.67%
IGL 396.80 -5.51%
IGL 396.80 -5.51%
GPPL 87.15 -5.43%
NOIDATOLL 7.50 -5.06%
GODHA 2.85 -5.00%
TRF 276.15 -4.99%
SUBCAPCITY 112.55 -4.98%
PVP 8.70 -4.92%
 
 
IPCALAB
Daily Charts
IPCALAB
Intraday Charts
Whats New @
Bazaartrend
IPCALAB
Free Analysis
 
IPCALAB Important Levels Intraday
RESISTANCE956.33
RESISTANCE943.08
RESISTANCE934.88
RESISTANCE926.69
SUPPORT903.31
SUPPORT895.12
SUPPORT886.92
SUPPORT873.67
 
IPCALAB Target October 2022
4th UP Target1370.48
3rd UP Target1250.93
2nd UP Target1177.03
1st UP Target1103.13
1st DOWN Target892.27
2nd DOWN Target818.37
3rd DOWN Target744.47
4th DOWN Target624.92
 
IPCALAB Weekly Target
4th UP Target968.08
3rd UP Target937.89
2nd UP Target919.23
1st UP Target900.57
1st DOWN Target847.33
2nd DOWN Target828.67
3rd DOWN Target810.01
4th DOWN Target779.82
 
IPCALAB Target2022
4th UP Target4056.8
3rd UP Target3450.67
2nd UP Target3076
1st UP Target2701.34
1st DOWN Target1632.26
2nd DOWN Target1257.6
3rd DOWN Target882.93
4th DOWN Target276.8
 
 
IPCALAB Synopsis Technicals View
50 Day EMA Close is Below EMA 50 (Short Term)
Bearish
100 Day EMA Close is Below EMA 100 (Mid Term) Bearish
200 Day EMA Close is Below EMA 200 (Long Term) Bearish
MACD (12 26 9) MACD Line is Less Then SIGNAL Line Bearish
RSI (14) RSI is 44.05 Sideways
MFI (14) MFI is 38.99 Sideways
CCI (20) CCI is Below -100 Over Sold
WILLIAM %R (14) William %R is Below -80 Over Sold
ADX (14) ADX is Above 20 & +DI is Above -DI Up Trend
PSAR Stoploss For Short Sell 1500.45
10 Day Avg Volume Traded -25.56 % Less then 10 Day Average Volume
 
IPCALAB Other Details
Segment EQ
Market Capital 278177841152.00
Sector Healthcare
Industry Drug Manufacturers-Specialty & Generic
Offical website >
 
IPCALAB Address
IPCALAB
 
IPCALAB Latest News
 
Your Comments and Response on IPCA Laboratories Limited
 
IPCALAB Business Profile
Ipca Laboratories Limited manufactures and markets pharmaceutical formulations and active pharmaceutical ingredients (APIs) for various therapeutic segments in India. The company offers APIs in therapeutic areas of anti-hypertensive, anti-malarial, diuretic, DMARD, and anthelmintic. It also provides generic and branded formulations in the therapeutic segments, including cardiology, gastroenterology, dermatology, rheumatology, urology, ophthalmology, infectious disease, immunosuppressant, probiotics, respiratory, allergy, nutraceuticals, anti-neoplastic, malarial, neurology, psychiatry, orthopedics, helminthics, fever, hematology, hepatoprotective, diabetology, anti-epileptic, emollients/protectives, NSAIDs, rheumatology, anti-arthritic, and neuropathic pain, as well as products in various dosage forms comprising oral solids, powders for suspension, and liquid and dry injections. The company exports its products to approximately 100 countries worldwide. Ipca Laboratories Limited was incorporated in 1949 and is based in Mumbai, India. Address: 125, Kandivli Industrial Estate, Mumbai, India, 400067
 
2005-2021 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service